Patent · US Active

Anti-HtrA1 antibodies and methods of use

US9738727B2 · kind B2 · utility

5Cited by
112References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 12, 2012
Grant dateAug 22, 2017
Priority date
Expiry dateJul 19, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-HtrA1 antibodies and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.